A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment

Marc L. Hyer(Takeda (United States)), Neil Bence(Nurix (United States)), Anya Lublinsky(Takeda (United States)), Lawrence R. Dick(Millennium Engineering and Integration (United States)), Katherine Galvin(Takeda (United States)), Jim Brownell(Takeda (United States)), Petter O. Veiby(Takeda (United States)), Stephen Tirrell(Takeda (United States)), Jessica J. Huck(Takeda (United States)), Jennifer Duffy(Takeda (United States)), Paul D. Greenspan(Takeda (United States)), Claudia Rabino(Takeda (United States)), Saurabh Menon(Takeda (United States)), Michael D. Sintchak(Millennium Engineering and Integration (United States)), Paul Fleming(Blueprint Medicines (United States)), Jeff Ciavarri(Takeda (United States)), Michael A. Milhollen(Millennium Engineering and Integration (United States)), Teresa A. Soucy(Millennium Engineering and Integration (United States)), Mike Kuranda(Takeda (United States)), Jing Wu(Takeda (United States)), Kara M. Hoar(Takeda (United States)), Chris Claiborne(Takeda (United States)), Steven Langston(Takeda (United States)), James M. Gavin(Millennium Engineering and Integration (United States)), Judy Shi(Takeda (United States)), Darshan S. Sappal(Takeda (United States)), Frank J. Bruzzese(Millennium Engineering and Integration (United States)), Jessica Riceberg(Takeda (United States)), Yang Yu(Children's National), Ping Li(Anhui Medical University), Robert Griffin(Takeda (United States)), Sai Murali Krishna Pulukuri(Takeda (United States)), Bradley Stringer(Takeda (United States)), Benjamin Amidon(Takeda (United States)), John Newcomb(Takeda (United States)), Josh Powe(Takeda (United States)), Tary Traore(Millennium Engineering and Integration (United States)), Nancy J. Bump(Millennium Engineering and Integration (United States)), Mark Manfredi(Millennium Engineering and Integration (United States))
Nature Medicine
January 15, 2018
Cited by 453


Related Papers